Research output per year
Research output per year
Personal profile
Research interests
My laboratory is engaged in translational research focused on investigating genetic and pharmacogenetic associations with cardiovascular disease, with a particular interest in diabetic cardiovascular disease. Ongoing projects in my laboratory include 1) comprehensively investigating the genetic and pharmacogenetic associations of PPAR-pathway variants, using a custom PPAR-pathway targeted-genotyping 3K array, in a population with type 2 DM and coronary artery disease that has been extensively phenotyped (BARI 2D cohort); 2) assessing the predictive impact of genetic variants in the context of modern post-ACS therapy in a cohort of 4,500 patients with acute myocardial infarction (TRIUMPH cohort).
Clinical interests
Transthoracic, transesophageal and stress echocardiograms, hypertrophic cardiomyopathy.
Keywords
- COVID-19
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Sharon Cresci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Effect of Mavacamten in Women Compared with Men with Obstructive Hypertrophic Cardiomyopathy: Insights from EXPLORER-HCM
Cresci, S., Bach, R. G., Saberi, S., Owens, A. T., Spertus, J. A., Hegde, S. M., Lakdawala, N. K., Nilles, E. K., Wojdyla, D. M., Sehnert, A. J. & Wang, A., Feb 13 2024, In: Circulation. 149, 7, p. 498-509 12 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Exercise Testing to Unmask Latent LVOT Obstruction in a Highly Symptomatic Patient With Hypertrophic Cardiomyopathy
Husaini, M., Bach, R. G. & Cresci, S., Aug 6 2024, In: Journal of the American College of Cardiology. 84, 6, p. 602-606 5 p.Research output: Contribution to journal › Article › peer-review
-
Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension: Post-Hoc Analysis of the EXPLORER-HCM Trial
Wang, A., Spertus, J. A., Wojdyla, D. M., Abraham, T. P., Nilles, E. K., Owens, A. T., Saberi, S., Cresci, S., Sehnert, A. & Lakdawala, N. K., Mar 2024, In: JACC: Heart Failure. 12, 3, p. 567-579 13 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Safety and Efficacy of Metabolic Modulation With Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy
Maron, M. S., Mahmod, M., Abd Samat, A. H., Choudhury, L., Massera, D., Phelan, D. M. J., Cresci, S., Martinez, M. W., Masri, A., Abraham, T. P., Adler, E., Wever-Pinzon, O., Nagueh, S. F., Lewis, G. D., Chamberlin, P., Patel, J., Yavari, A., Dehbi, H. M., Sarwar, R. & Raman, B. & 4 others, , May 28 2024, In: Journal of the American College of Cardiology. 83, 21, p. 2037-2048 12 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Inequities in Treatments and Outcomes Among Patients Hospitalized With Hypertrophic Cardiomyopathy in the United States
Johnson, D. Y., Waken, R. J., Fox, D. K., Hammond, G., Joynt Maddox, K. E. & Cresci, S., 2023, In: Journal of the American Heart Association. 12, 11, e029930.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations